Dual & Triple Agents

Better blood sugar control

• Studies show:

• Regular GLP-1 meds lower A1C about 1–1.8%

• Tirzepatide can lower A1C up to 2.4%

• Triple agonists show similar or even stronger effects in early research

• This means many people see better diabetes control even if past medications didn’t work well enough.

Stronger and more consistent weight loss

• These medicines work on the brain areas that control hunger, cravings, and fullness.

• People in major clinical trials lost:

• 15–22% of their body weight on tirzepatide

• Up to 24% on retatrutide — the highest weight loss ever seen in medication studies

  • Many people say they:

• Get full quicker

• Think about food less

• Have fewer cravings

• Can stick to healthier habits more easily

Why Do Triple Agonists Work So Well? 

• The triple agonist (retatrutide) also boosts your metabolism — meaning your body burns more calories naturally.

• Even though one of the hormones it activates (glucagon) normally raises blood sugar, the medication balances this perfectly, so blood sugar doesn’t spike.

  • The result:

    • Stronger fat-burning and more weight loss without loss of blood sugar control.

Who These Medicines May Help 

• Dual and triple agonists may be a good fit for:

  • People with type 2 diabetes who need stronger blood sugar control

  • Anyone with obesity, or a BMI of 27+ with weight-related health issues

  • People who plateaued or didn’t respond strongly to semaglutide or other GLP-1s

  • People with fatty liver, insulin resistance, or trouble losing weight despite trying